Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Russell Ray Insider Profile
4 Followers
Russell Ray, Director at Merrimack Pharmaceuticals, holds 24.41K shares in 180 Life Sciences (Ticker: ATNF), holds 0.00 shares in Allergan (Ticker: AGN), holds 10.00K shares in Merrimack Pharmaceuticals (Ticker: MACK).
Russell Ray has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Russell Ray holds in companies
Most Profitable Insider Trade
Stock:
Allergan
(AGN)
(AGN)
Rating:Informative Sell
Date:Nov 26, 2012 - Nov 26, 2013
Return:-87.90%
The most profitable trade made by Russell Ray
Russell Ray's Trading History
Merrimack Pharmaceuticals
Jan 08, 2015
Director
Uninformative Buy
―
$147.40K
180 Life Sciences
Sep 08, 2023
Director
Uninformative Buy
29.18K
$52.48K
Allergan
Mar 19, 2015
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Russell Ray's performance on stock
You May Also Like
Russell Ray insider profile FAQ
What is the percentage of profitable transactions made by Russell Ray?
The percentage of profitable transactions made by Russell Ray is ―.
What is the average return per transaction made by Russell Ray?
The average return per transaction made by Russell Ray is ―.
What stocks does Russell Ray hold?
Russell Ray holds: MACK, ATNF, AGN stocks.
What was Russell Ray’s latest transaction?
Russell Ray latest transaction was an Uninformative Buy of $29.18K.
What was Russell Ray's most profitable transaction?
Russell Ray’s most profitable transaction was an Informative Sell of AGN stock on November 26, 2012. The return on the trade was -87.90%.
What is Russell Ray's role in Merrimack Pharmaceuticals?
Russell Ray's role in Merrimack Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.